Supplementary Protection Certificate Search

Details

SPC number
SPC/GB14/062
Filing date
12 September 2014

Applicant(s) details

Name
Merck Sharp & Dohme Corp.
Address
126 East Lincoln Avenue
Rahway
New Jersey 07065
United States of America

Agent details

Name
Merck Sharp & Dohme LLC
Address
120 Moorgate
London
EC2M 6UR


Patent details

Patent number
EP0720599
Title
Hydroxy- substituted azetidinone compounds useful as hypocholestrolemic agents.

UK authorisation details

Authority date
10 September 2014
UK authorisations
  • DE/H/3895-3898/001DC
  • DE/H/3895-3898/002DC
  • DE/H/3895-3898/003DC
  • DE/H/3895-3898/004DC

Product details

Product description
Ezetimibe and atorvastatin or pharmaceutically acceptable salts thereof, including atorvastatin as atorvastatin as atorvastatin calcium trihydrate. Active ingredients:ezetimibe and atorvastatin calcium trihydrate. Proprietary name: ATOZET
Status
Lodged
Product type
Medicinal

Life details

In force date
Actual expiry date
Maximum expiry date
Invalid date
Lapsed date
Lapsed status

Extension details

Lodged date
Granted date
Refused date
Revoked date
Expiry date
Authorisation number
Authorisation date
Information concerning revocation actions and other legal proceedings on an SPC is included in the Patents Status Information record of the relevant patent.